from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3236c/-

LFCtreatmentdescriptionclass of inhibitor

-0.001

Amikacinug/mL Amikacintranslation

0.278

Cap5-10ug/mL Capreomycintranslation

-0.024

Rox10-50 ug/mL Roxithromycintranslation

-0.473

SM2-5 ug/mL Streptomycintranslation

-0.587

Tet5-10 ug/mL Tetracyclinetranslation

0.357

Rif0.2-5ug/mL Rifampicintranscription

0.475

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.148

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.093

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.512

CPZ10-50 ug/mL Chlorpromazinerespiration

0.269

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.158

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.019

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.370

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.016

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.316

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.541

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.122

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.737

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.190

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.452

KCN5-20 ug/mL Potassium cyaniderespiration

0.073

NaN30.2-2 mM Sodium aziderespiration

-1.233

Nigericin50 uM Nigericinrespiration

0.332

TRC10-150 ug/mL Triclosanrespiration

-0.828

TRZ10-25 ug/mL Thioridazinerespiration

-0.367

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.095

menadione6-10 ug/mL Menadionerespiration

0.690

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.169

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.244

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.100

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.398

NRP_1Non-replicating persistence stage 1dosRassociated

-0.174

Amp0.2mg/mL AmpicillincellWall

-0.274

Cephalexin20-100 ug/mL CephalexincellWall

-0.481

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.533

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.444

EMB10-20 ug/mL EthambutolcellWall

-0.934

Eta12-40 ug/mL EthionamidecellWall

-1.054

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.538

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.479

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.198

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.004

BZA0.12 mg/mL BenzamidearomaticAmides

0.308

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.014

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.233

H2O24 mM hydrogen peroxideDNAdamaging

0.592

Levo10 ug/mL LevofloxacinDNAdamaging

0.220

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.419

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.735

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.008

UVUV-irradiationDNAdamaging

1.345

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.189

Antimycin12.5-50 ug/mL Antimycin A?

-0.740

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.475

PA_110-50 ug/mL Antitubercular compound PA-1?

0.509

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.751

PA8240.2-2 ug/mL PA-824?

-0.007

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.371

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.004

Verapamil50 uM Verapamil?

-0.672

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.859

methoxatin10-20 ug/mL Methoxatin?